Published in Chest on February 01, 1992
Dyspnea during daily activities in chronic spinal cord injury. Arch Phys Med Rehabil (2005) 0.99
Reproducibility of four-dimensional computed tomography-based lung ventilation imaging. Acad Radiol (2012) 0.89
Strategy for respiratory exercise pattern associated with upper limb movements in COPD patients. Clinics (Sao Paulo) (2011) 0.81
Sequential Posture Change Fastens Gastric Emptying of Large Volume Bolus Intake of Normal Saline: A Pilot Study. Dig Dis Sci (2015) 0.75
Systemic manifestations and comorbidities of COPD. Eur Respir J (2009) 5.90
Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J (2008) 5.38
Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med (2001) 4.01
C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax (2005) 2.72
Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization. N Engl J Med (1987) 2.64
The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J (2004) 2.63
Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax (2003) 2.54
Idiopathic pulmonary fibrosis: predicting response to therapy and survival. Am J Respir Crit Care Med (1998) 2.43
Steroids in idiopathic pulmonary fibrosis: a prospective assessment of adverse reactions, response to therapy, and survival. Am J Med (2001) 2.35
C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J (2006) 2.33
Short-term and long-term outcomes after bilateral lung volume reduction surgery : prediction by quantitative CT. Chest (2001) 2.26
Pulmonary rehabilitation and the BODE index in COPD. Eur Respir J (2005) 2.23
Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring. AJR Am J Roentgenol (1997) 2.19
Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J (2002) 2.19
Prevalence and clinical correlates of bronchoreversibility in severe emphysema. Eur Respir J (2009) 2.18
Validation and comparison of reference equations for the 6-min walk distance test. Eur Respir J (2007) 2.04
Long-term controlled trial of nocturnal nasal positive pressure ventilation in patients with severe COPD. Chest (2000) 1.94
The 6-min walk distance in healthy subjects: reference standards from seven countries. Eur Respir J (2010) 1.90
Comparison of disease progression and mortality of connective tissue disease-related interstitial lung disease and idiopathic interstitial pneumonia. Arthritis Rheum (2005) 1.79
Sex differences in mortality in patients with COPD. Eur Respir J (2008) 1.79
Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 1.76
Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD? Eur Respir J (2008) 1.76
Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: role of IL-8. J Immunol (1996) 1.58
Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin. Lung volumes, volume-pressure relations, carbon monoxide uptake, and arterial blood gas studied. Am Rev Respir Dis (1978) 1.57
International approaches to the prescription of long-term oxygen therapy. Eur Respir J (2001) 1.57
Unexplained exertional limitation: characterization of patients with a mitochondrial myopathy. Am J Respir Crit Care Med (2001) 1.56
Localized amyloidosis of the lower respiratory tract. Am Rev Respir Dis (1978) 1.54
High-resolution CT detection of lacerations in the transplanted lung after transbronchial biopsy. J Thorac Imaging (1994) 1.42
Risk of pneumothorax in CT-guided transthoracic needle aspiration biopsy of the lung. Radiology (1996) 1.36
The effect of dialysates and ultrafiltrates of plasma of saline-loaded dogs on toad bladder sodium transport. J Clin Invest (1970) 1.33
Increased gastro-oesophageal reflux disease in patients with severe COPD. Eur Respir J (2004) 1.29
Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema. Eur Respir J (2010) 1.26
Lung-volume reduction improves dyspnea, dynamic hyperinflation, and respiratory muscle function. Am J Respir Crit Care Med (1997) 1.21
Effects of hyperinflation on the oxygen pulse as a marker of cardiac performance in COPD. Eur Respir J (2008) 1.20
Inhaled nitric oxide in primary pulmonary hypertension: a safe and effective agent for predicting response to nifedipine. J Am Coll Cardiol (1998) 1.20
Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension. Eur Respir J (2001) 1.19
Limitations of randomized clinical trials for evaluating emerging operations: the case of lung volume reduction surgery. Ann Thorac Surg (2001) 1.16
Patterns of pulmonary involvement in systemic amyloidosis. Chest (1978) 1.15
A controlled trial of intermittent positive pressure breathing, incentive spirometry, and deep breathing exercises in preventing pulmonary complications after abdominal surgery. Am Rev Respir Dis (1984) 1.15
Pleuropulmonary manifestations of systemic lupus erythematosus. Rheum Dis Clin North Am (1994) 1.14
Spectrum of Aspergillus infection in lung transplant recipients: case series and review of the literature. Chest (2001) 1.13
Substrate specificity of human aldose reductase: identification of 4-hydroxynonenal as an endogenous substrate. Biochim Biophys Acta (1995) 1.11
Respiratory muscle and cardiopulmonary function during exercise in very severe COPD. Am J Respir Crit Care Med (1996) 1.10
Endobronchial ultrasound-guided needle aspiration of mediastinal adenopathy. Am J Respir Crit Care Med (1996) 1.09
The 6-min walking distance: long-term follow up in patients with COPD. Eur Respir J (2006) 1.09
Synthesis and anti-HIV activity of 1,1'-dideoxygossypol and related compounds. J Med Chem (1995) 1.06
Accessory cardiac bronchus presenting with haemoptysis. Thorax (1997) 1.03
Lung function estimates in idiopathic pulmonary fibrosis: the potential for a simple classification. Thorax (2005) 1.03
Long-term oxygen therapy. N Engl J Med (1995) 1.02
Pneumomediastinum in a 63-year-old woman with asthma exacerbation. Chest (2000) 1.02
Idiopathic pulmonary fibrosis fibroblasts migrate and proliferate to CC chemokine ligand 21. Eur Respir J (2007) 1.01
Improved diaphragmatic function after surgical plication for unilateral diaphragmatic paralysis. Am Rev Respir Dis (1992) 1.01
The modified BODE index: validation with mortality in COPD. Eur Respir J (2008) 0.99
Focal interstitial CC chemokine receptor 7 (CCR7) expression in idiopathic interstitial pneumonia. J Clin Pathol (2006) 0.99
Dyssynchronous breathing during arm but not leg exercise in patients with chronic airflow obstruction. N Engl J Med (1986) 0.99
Augmented pulmonary IL-4 and IL-13 receptor subunit expression in idiopathic interstitial pneumonia. J Clin Pathol (2004) 0.99
Stenosis of the central airways: evaluation by using helical CT with multiplanar reconstructions. Radiology (1995) 0.97
Predicting complications after pulmonary resection. Preoperative exercise testing vs a multifactorial cardiopulmonary risk index. Chest (1993) 0.97
TLR9 is expressed in idiopathic interstitial pneumonia and its activation promotes in vitro myofibroblast differentiation. Histochem Cell Biol (2008) 0.96
Quality and reproducibility of spirometry in COPD patients in a randomized trial (UPLIFT®). Respir Med (2013) 0.96
The obesity hypoventilation syndrome can be treated with noninvasive mechanical ventilation. Chest (2001) 0.95
The sensitivity of high-resolution CT in detecting idiopathic pulmonary fibrosis proved by open lung biopsy. A prospective study. Chest (1995) 0.94
Community-acquired pneumonia. Curr Opin Pulm Med (1998) 0.92
Hypothyroidism. A reversible cause of diaphragmatic dysfunction. Chest (1989) 0.92
Effect of unsupported arm exercise on ventilatory muscle recruitment in patients with severe chronic airflow obstruction. Am Rev Respir Dis (1988) 0.91
Factors influencing ventilatory muscle recruitment in patients with chronic airflow obstruction. Am Rev Respir Dis (1990) 0.91
Noninvasive positive pressure ventilation and not oxygen may prevent overt ventilatory failure in patients with chest wall diseases. Chest (1997) 0.90
Respiratory response to arm elevation in patients with chronic airflow obstruction. Am Rev Respir Dis (1991) 0.89
Is pulmonary rehabilitation an effective treatment for chronic obstructive pulmonary disease? Yes. Am J Respir Crit Care Med (1997) 0.89
Dose escalation for non-small cell lung cancer using conformal radiation therapy. Int J Radiat Oncol Biol Phys (1997) 0.88
Arm training reduces the VO2 and VE cost of unsupported arm exercise and elevation in chronic obstructive pulmonary disease. J Cardiopulm Rehabil (1997) 0.87
Limitations of spirometry in detecting rejection after single-lung transplantation. Am J Respir Crit Care Med (1994) 0.86
Pulmonary smooth muscle proliferation occurring after lung transplantation. Chest (1997) 0.86
Semi-quantitative ventilation/perfusion scintigraphy and single-photon emission tomography for evaluation of lung volume reduction surgery candidates: description and prediction of clinical outcome. Eur J Nucl Med (1999) 0.86
The role of pulmonary function testing in pulmonary fibrosis. Curr Opin Pulm Med (2000) 0.86
Pulmonary function tests in interstitial lung disease: what role do they have? Clin Chest Med (2001) 0.86
Cardiopulmonary exercise testing following allogeneic lung transplantation for different underlying disease states. Chest (1995) 0.86
Preoperative echocardiographic evaluation of patients referred for lung volume reduction surgery. Chest (1998) 0.85
Postoperative pulmonary complications. Med Clin North Am (2001) 0.84
Sex differences in physiological progression of idiopathic pulmonary fibrosis. Eur Respir J (2008) 0.84
Lung and heart-lung transplant practice patterns in pulmonary hypertension centers. J Heart Lung Transplant (2001) 0.84
Chromobacterium violaceum as a cause of periorbital cellulitis. Pediatr Infect Dis (1985) 0.84
Cyclophosphamide in the treatment of idiopathic pulmonary fibrosis: a prospective study in patients who failed to respond to corticosteroids. Chest (2000) 0.83
Mouth occlusion pressure, CO2 response and hypercapnia in severe chronic obstructive pulmonary disease. Eur Respir J (1998) 0.83
Transthoracic needle aspiration in patients with severe emphysema. A study of lung transplant candidates. Chest (1996) 0.82
Pulmonary rehabilitation that includes arm exercise reduces metabolic and ventilatory requirements for simple arm elevation. Chest (1993) 0.82
Sarcoidosis presenting as a tumorlike muscular lesion. Case report and review of the literature. Medicine (Baltimore) (1999) 0.81
Acute pneumonitis after subcutaneous injections of silicone. N Engl J Med (1983) 0.81
The light at the end of the tunnel: is COPD prevalence changing? Eur Respir J (2010) 0.81
Respiratory muscle testing. Clin Chest Med (2001) 0.81
Increased interleukin-1 receptor antagonist in idiopathic pulmonary fibrosis. A compartmental analysis. Am J Respir Crit Care Med (1995) 0.81
Nonspecific interstitial pneumonia (NSIP). Semin Respir Crit Care Med (2001) 0.81
Weaning from mechanical ventilation. Int Anesthesiol Clin (1999) 0.81
Correlations between dyspnea, diaphragm and sternomastoid recruitment during inspiratory resistance breathing in normal subjects. Chest (1990) 0.81
Respiratory muscle recruitment and exercise performance in eucapnic and hypercapnic severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 0.80
Lung volume reduction surgery for emphysema. Clin Chest Med (2000) 0.80
Ventilatory drive at rest and perception of exertional dyspnea in severe COPD. Chest (1999) 0.79